Andreas W. Herling. 2016. Drug Discovery and Evaluation: Pharmacological Assays. Drug Discovery and Evaluation: Pharmacological Assays
2341
2413
.
Andreas W. Herling. 2014. Drug Discovery and Evaluation: Pharmacological Assays. Drug Discovery and Evaluation: Pharmacological Assays
1
87
.
Sascha Kopic & John P. Geibel. (2013) Gastric Acid, Calcium Absorption, and Their Impact on Bone Health. Physiological Reviews 93:1, pages 189-268.
Crossref
Andreas W. Herling. 2013. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays
199
255
.
Lennart Friis-Hansen. (2007) Lessons from the gastrin knockout mice. Regulatory Peptides 139:1-3, pages 5-22.
Crossref
Hans Gerhard Vogel. 2008. Drug Discovery and Evaluation. Drug Discovery and Evaluation
1191
1321
.
Andreas W. Herling. 2006. Drug Discovery and Evaluation. Drug Discovery and Evaluation
151
193
.
Maria Tzaneva. (2004) Effects of duodenogastric reflux on gastrin cells, somatostatin cells and serotonin cells in human antral gastric mucosa. Pathology - Research and Practice 200:6, pages 431-438.
Crossref
H. Gerhard Vogel, Wolfgang H. Vogel, Bernward A. Schölkens, Jürgen Sandow, Günter Müller & Wolfgang F. Vogel. 2002. Drug Discovery and Evaluation. Drug Discovery and Evaluation
827
945
.
M. Tzaneva. (2001) Light and electron microscopic immunohistochemical investigation on G and D cells in antral mucosa in Helicobacter pylori-related gastritis. Experimental and Toxicologic Pathology 52:6, pages 523-528.
Crossref
Sema Bolkent, Selma Yilmazer, Fatma Kaya & Melek Öztürk. (2001) Effects of acid inhibition on somatostatin-producing cells in the rat gastric fundus. Acta Histochemica 103:4, pages 413-422.
Crossref
H. Gerhard Vogel & Wolfgang H. Vogel. 1997. Drug Discovery and Evaluation. Drug Discovery and Evaluation
461
534
.
Andreas W. Herling & Klaus Weidmann. 1994.
233
264
.
C. B. H. W. Lamers. 1993. Der Magen. Der Magen
43
51
.
C. B. H. W. Lamers. 1993. The Stomach. The Stomach
38
45
.
Tiziana D'Adda, Francesco P. Pilato, Marco Lazzaroni, Flavio Robutti, Gabriele Bianchi-Porro & Cesare Bordi. (1991) Ultrastructural morphometry of gastric endocrine cells before and after omeprazole. Gastroenterology 100:6, pages 1563-1570.
Crossref
P. N. Maton, G. Sachs & B. Wallmark. 1991. Pharmacology of Peptic Ulcer Disease. Pharmacology of Peptic Ulcer Disease
159
187
.
J. Van Dam & M. M. Wolfe. 1991. Pharmacology of Peptic Ulcer Disease. Pharmacology of Peptic Ulcer Disease
55
88
.
CJ Gavey, JT Smith, CU Nwokolo & RE Pounder. (2012) Clofibrate raises human 24 h intragastric acidity but does not affect plasma gastrin concentration.. British Journal of Clinical Pharmacology 29:4, pages 473-477.
Crossref
Kenneth G. Wormsley. (1989) Therapeutic achlorhydria and risk of gastric cancer. Gastroenterologia Japonica 24:5, pages 585-596.
Crossref
C. T. EASON, A. J. SPENCER, A. PATTISON & F. W. BONNER. (2007) The trophic effects of gastrin on fundic neuroendocrine cells of the rat stomach. Alimentary Pharmacology & Therapeutics 3:3, pages 245-251.
Crossref
T. Lehy, M. Mignon, G. Cadiot, L. Elouaer-Blanc, Ph. Ruszniewski, M.J.M. Lewin & S. Bonfils. (1989) Gastric endocrine cell behavior in Zollinger-Ellison patients upon long-term potent antisecretory treatment. Gastroenterology 96:4, pages 1029-1040.
Crossref
Andrew J. Spencer, Thomas A. Barbolt, Douglas C. Henry, Charles T. Eason, Richard J. Sauerschell & Frank W. Bonner. (2016) Gastric Morphological Changes Including Carcinoid Tumors in Animals Treated with a Potent Hypolipidemic Agent, Ciprofibrate. Toxicologic Pathology 17:1_part_1, pages 7-15.
Crossref
C.T. Eason, A.J. Spencer, A. Pattison, D.D. Howells, D.C. Henry & F.W. Bonner. (1988) Species variation in gastric toxicity following chronic administration of ciprofibrate to rat, mouse, and marmoset. Toxicology and Applied Pharmacology 95:2, pages 328-338.
Crossref
G. CADIOT, THERESE LEHY & S. BONFILS. (2008) Action of somatostatin analogue (SMS 201–995) on the growth‐promoting effect resulting from sustained achlorhydria in rat gastric mucosa, with special reference to endocrine cell behaviour. European Journal of Clinical Investigation 18:4, pages 360-368.
Crossref